ADAM10 expression in gastric adenocarcinoma: Results of a curative gastrectomy cohort | Zendy

Hüseyin Alakuş | Zendy; Mustafa Kaya | Zendy; Hatice Özer | Zendy; Hatice Reyhan Eğilmez | Zendy; Kürşat Karadayı | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

ADAM10 expression in gastric adenocarcinoma: Results of a curative gastrectomy cohort

Author(s) -

Hüseyin Alakuş,

Mustafa Kaya,

Hatice Özer,

Hatice Reyhan Eğilmez,

Kürşat Karadayı

Publication year - 2021

Publication title -

pakistan journal of medical sciences

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.316

H-Index - 30

eISSN - 1682-024X

pISSN - 1681-715X

DOI - 10.12669/pjms.37.2.3613

Subject(s) - medicine , immunohistochemistry , adam10 , adenocarcinoma , univariate analysis , gastrectomy , cancer , lymph node , gastric adenocarcinoma , multivariate analysis , gastroenterology , stage (stratigraphy) , pathology , oncology , metalloproteinase , disintegrin , matrix metalloproteinase , paleontology , biology

Gastric cancer is among the most common human cancers with high mortality rates. ADAM10, a member of the ADAM (a disintegrin and metalloproteinase) family has also been found to be associated with gastric carcinoma and has been suggested as a potential therapeutic target. Here, we investigated the association of ADAM10 expression with prognosis in gastric adenocarcinoma patients that underwent gastric resection with D2 lymph node dissection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research